Therefore, to evaluate whether combining tamoxifen with TNFα treatment or suppression of NCOR1 can potentially overcome tamoxifen resistance by enhancing the drug sensitivity of tumor cells, TNFα treatment or NCOR1 knockdown were conducted in the presence or absence of tamoxifen in MCF7 xenograft mice for 14 days. Here, NCOR1 is linked to neoplasm.